Method specific guidance
| CEU advice - Yasmin® and VTE | April 2010 |  |
| Progestogen-only Pills | Updated June 2009 | |
| Progestogen-only Injectable Contraception | Updated June 2009 | |
| Recommendation from the CEU: Antibiotic prophylaxis for intrauterine contraceptive use in women at risk of bacterial endocarditis | July 2008 | |
| Progestogen-only Implants | April 2008 | |
| Intrauterine Contraception | November 2007 | |
| Female Barrier Methods | June 2007 | |
| Condoms - Male and Female | January 2007 | |
| Combined Oral Contraception - First Prescription of COC | Updated January 2007 | |
| Combined Oral Contraception - Missed Pills | April 2005 | |
| Depo Provera and Young people - Faculty statement | November 2004 | |
Emergency contraception
| Ulipristal (EllaOne) FAQs – Faculty Statement from the CEU | December 2009 | |
| Emergency contraception guidance | April 2006 | |
| Emergency contraception (Levonelle 1500) and liver enzyme inducing drugs | November 2005 | |
Contraception for special groups
| Contraception for women aged over 40 years | July 2010 | |
| Contraceptive choices for young people | March 2010 | |
| Postnatal Sexual and Reproductive Health | September 2009 | |
| Sexual and Reproductive Health for Individuals with Inflammatory Bowel Disease | June 2009 | |
| Oral Contraceptive Use And Cancer Risk | September 2007 | |
| Depo Provera and Young people - Faculty statement | November 2004 | |
Drug Interactions
Guidance Developed in Collaboration with other Organisations
Legal and drug licensing issues
| Joint statement with CEU regarding off- label prescribing | December 2009 | |
New Product Reviews & Statements
| CEU Statement - Nexplanon® | September 2010 | |
| Ulipristal Acetate (ellaOne®) | October 2009 | |
| The estradiol valerate / dienogest combined pill, Qlaira® | September 2009 | |
| Combined Vaginal Ring (NuvaRing®) | March 2009 | |
| FemCap – vaginal barrier contraceptive | October 2004 | |
| Evra - Norelgestromin/ethinyl oestradiol transdermal contraceptive system | October 2003 | |
| Cerazette - Desogestrel-only pill | April 2003 | |
Consultation on guidelines during development
| None at present |
ARCHIVED GUIDANCE
| Title | Date of Publication | Date Archived | View Paper |
UK adaptation of WHO Guidance | |||
| The UK Medical Eligibility Criteria for Contraceptive Use (2005/2006) | 2005-2006 | November 2009 | view |
Method specific guidance | |||
| IUS - The levonorgestrel-releasing intrauterine system in contraception and reproductive health | April 2004 | August 2009 | view |
| IUD - The Copper Intrauterine Device as Long-term Contraception | January 2004 | August 2009 | view |
Contraception for special groups | |||
| Contraception for women aged over 40 years | January 2005 | July 2010 | view |
| Contraceptive choices for young people | July 2004 | March 2010 | view |
| Contraceptive choices for breastfeeding women | October 2004 | September 2009 | view |
| Contraceptive Choices for Women with Inflammatory Bowel Disease | July 2003 | June 2009 | view |
Drug Interactions | |||
| Lamotrigine and interactions with hormonal contraceptives | August 2005 | January 2010 | view |
Consultation on guidelines during development | |||
| Feedback on First Prescription of Combined Oral Contraception Guidance | 2006 | October 2009 | view |
Legal and drug licensing issues | |||
| The use of contraception outside the terms of the product licence | July 2005 | March 2010 | view |
5 July 2010